Similar articles

• Bezafibrate: lack of effect on creatinine excretion and muscular proteins.

  Mertz DP, Lang PD, Vollmar J. Mertz DP, et al. Res Exp Med (Berl). 1982;180(1):95-8. doi: 10.1007/BF01852236. Res Exp Med (Berl). 1982. PMID: 7079594
• [Rhabdomyolysis with acute renal failure due to bezafibrate].

  Heidemann H, Bock KD. Heidemann H, et al. Klin Wochenschr. 1981 Apr 15;59(8):413-4. doi: 10.1007/BF01698522. Klin Wochenschr. 1981. PMID: 7289450 German. No abstract available.
• [Does hypothyroidism potentialize muscular toxicity of fibrates?].

  Harlé JR, Toussirot E, Disdier P, Drancourt M, Weiller PJ. Harlé JR, et al. Rev Med Interne. 1990 Jul-Aug;11(4):336. doi: 10.1016/s0248-8663(05)80871-9. Rev Med Interne. 1990. PMID: 2096444 French. No abstract available.
• Effects of fibric acid derivatives on biliary lipid composition.

  Palmer RH. Palmer RH. Am J Med. 1987 Nov 27;83(5B):37-43. doi: 10.1016/0002-9343(87)90869-2. Am J Med. 1987. PMID: 3318452 Review.
• Tolerability of fibric acids. Comparative data and biochemical bases.

  Sirtori CR, Calabresi L, Werba JP, Franceschini G. Sirtori CR, et al. Pharmacol Res. 1992 Oct-Nov;26(3):243-60. doi: 10.1016/1043-6618(92)90212-t. Pharmacol Res. 1992. PMID: 1437989 Review.